Synthesis of highly fluorescent GSH-CDTE nanoparticles (quantum dots)
09732272 · 2017-08-15
Assignee
Inventors
- Jose Manuel Perez Donoso (Santiago, CL)
- Juan Pablo Monras Charles (Santiago, CL)
- Igor Orlando Osorio-Roman (Santiago, CL)
- Claudio Chrisitan Vasquez Guzman (Santiago, CL)
Cpc classification
B82Y40/00
PERFORMING OPERATIONS; TRANSPORTING
Y10S977/95
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10S977/896
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
C09K11/88
CHEMISTRY; METALLURGY
C09K11/025
CHEMISTRY; METALLURGY
Y10S977/774
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
International classification
Abstract
The invention relates to a method for the synthesis of glutathione-capped cadmium-telluride (GSH-CdTe) quantum dots in an aqueous medium, including the steps of: a) preparing a precursor solution of cadmium in a citrate buffer; b) adding glutathione (GSH) to the preceding mixture via strong agitation; c) adding a telluride (potassium or sodium telluride) oxyanion as a telluride donor to the preceding mixture; d) allowing the preceding mixture to react; and e) stopping the reaction by incubation at low temperature.
Claims
1. A synthesis method in aqueous medium of cadmium-tellurium quantum dots joined with glutathione (CdTe-GSH), CHARACTERIZED in that it comprises the steps of: a. preparing an aqueous soluble cadmium salt solution in a buffer, the aqueous soluble cadmium salt solution having a pH of 9-13, the buffer being selected from the group consisting of a citrate buffer, a phosphate buffer, a Tris-HCL buffer, a Luria Bertani (LB) bacterial culture media buffer, and a MP buffer; b. adding glutathione (GHS) to the cadmium salt solution while applying agitation to from an agitated solution; c. adding a tellurium oxyanion as a tellurium donor, to the agitated solution of step b, the tellurium oxyanion being selected from the group consisting of sodium tellurite and potassium tellurite to from a composition; d. heating the composition from step c from 37° C. to 130° C. to from a reaction to provide a reactant solution; e. stopping the reaction by cooling the reactant solution to 4° C. to from a cooled solution; and f. incubating the cooled solution for at least 30 minutes.
2. The method according to claim 1, CHARACTERIZED in that in said step a, the cadmium salt in the aqueous soluble cadmium salt solution is selected from the group consisting of CdCl.sub.2, CdSO.sub.4 and Cd(CH.sub.3CO.sub.2).sub.2.
3. The method according to claim 1, CHARACTERIZED in that the composition of step c comprises CdCl.sub.2:GSH:K.sub.2TeO.sub.3 at a ratio of 4:10:1.
4. The method according to claim 1, CHARACTERIZED in that in step d, the reaction time is not greater than 24 hours.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) The patent of application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.
(2)
(3)
(4)
(5)
DETAILED DESCRIPTION OF THE INVENTION
(6) The synthesis of nanoparticles (NPs) or quantum dots (QDs) of CdTe-GSH in aqueous phase is conducted following this protocol:
(7) An aqueous CdCl.sub.2 solution is prepared (it can be any other salt of Cd.sup.+2 salt, such as cadmium sulphate, acetate or per-chlorate) up to a final concentration of 4 mM, in 50 ml 15 mM citrate buffer (it can be also Tris-HCl, phosphate, borax citrate Luria Bertani bacterial culture media or M9, among others), at pH9 (the pH may vary in the range of pH 9-13), at ambient temperature. M9 is a culture medium of microorganisms with the following composition:
(8) For 1 L of M9 medium, salts 100 mL 10× autoclave (Na.sub.2HPO.sub.4 anhydrous 60 g, KH.sub.2PO.sub.4 30 g, NaCl 5 g, NH4Cl 10 g in 1 L of nanopure water pH 7.2), nanopure sterile H.sub.2O 894 mL, MgSO.sub.4*4 mL 7H2O, CaCl.sub.2*0.1 mL 2H2O 1 M, glucose 20% 10 mL and hydrochloride thiamine 3 mL 0.1 M is required. MgSO.sub.4*7H2O, CaCl.sub.2*2H.sub.2O, glucose and the hydrochloride thiamine are all previously sterilized with 0.2 μm filters under a laminar flow cabinet.
(9) GSH up to a final concentration of 10 mM is added, under strong stirring or agitation (avoiding the forming of a white precipitate of Cd°).
(10) After 5-10 minutes ( ) a tellurium oxyanion is added as K.sub.2TeO.sub.3 (or Na.sub.2TeO.sub.3) at a final concentration of 1 mM. The component ratio in the final synthesis mixture CdCl.sub.2:GSH:K.sub.2TeO.sub.3 is 4:10:1, (however, the synthesis also allows other ratios as 1:2:1, and 6:10:1). At this stage, the solution turns to a light green color, which is indicative of the generation of the first nanoparticle “seeds”, that will be able to start the nucleation of the QDs, and increasing their size as the treatment time increases.
(11) To start the nucleation process (synthesis) of the QDs, the mixture should be heated up to 90° C. (T°); (the protocol is valid in the temperature range of 37-130° C.). The synthesis kinetic (velocity) of the QDs is proportional to the T° of the test: to a higher temperature (T°) corresponds a higher production kinetic of big sized QDs.
(12) From this point onward, the color of the solution changes with time, and its spectroscopic properties (absorption and fluorescence) vary as a consequence of QDs formation At different times samples can be collected to obtain QDs having the desired color and/or size. If the synthesis is conducted at 90° C., after 4 hours, the solution has presented different colors, and it stabilizes in a red color, which indicates the presence of the CdTe-GSH NPs of bigger size. The sizes of the QDs are comprised in the range of 2.5-3 nm diameter at the first time (green color) up to approximately 5-6.5 nm diameter for the red color suspension.
(13) If the synthesis is conducted at lower temperatures, for example 60° C., after 2 h the solution is a green fluorescence, and after approximately 20 h it turns to a reddish color (during this time, the solution has changed to different colors, different levels and intensities of green, yellow and red; as it occurs in the system at 50° C.).
(14) To stop the reaction it is necessary to reduce the temperature of the solution to 4° C. (keep the tubes in a glass case or in ice during at least 30 min). To maintain the properties of the synthesized QDs they should be stored at low temperature and in the dark. However, NPs which have been synthesized with this method, remain fluorescent for at least 6 months, when exposed to room temperature and/or to day light. To store and determine the mass of the synthesized QDs, it is possible to precipitate nanoparticles from the synthesis solution (or suspension) by treating it with 2 volumes of isopropanol and centrifuge during 20 min at 13,000× g. In this way, a highly fluorescent precipitate is obtained, which corresponds to CdTe-GSH QDs.
(15) Characteristics of the QDs Generated According to this Protocol
(16) With this process it is possible to obtain CdTe-GSH nanoparticles with characteristic absorption and fluorescence spectra (see
(17) The quantum efficiency of the produced QDs, according to this protocol is approximately 25-30%, depending of the nanoparticle size, being similar with that described in other synthesis methods.
(18) The composition of the nanoparticles was estimated by means of an EDAX analysis (Energy Dispersive X-Rays Analysis). It was determined that they contain approximately 35% C, 12% 0, 15.5% N, 5% S, 23.6% Cd, and 72% Te. The C, O, N, and S contents are those expected for the QDs which comprise a tripeptide as GSH. The Cd:Te ratio: was 3.3:1, which agrees with that described for CdTe-GSH nanoparticles synthesized by other methods. Together with the above cited analysis, an Atomic Force Microscopy (AFM) analysis and Dynamic Light Scattering (DLS) determined that the size of the QDs vary between 3-6 nm. The green, yellow, and red QDs displayed diameters of approximately 3, 4.2, and 5 nm, respectively.
(19) A direct application of these QDs, is their joining to a protein, particularly to antibodies, and their use in a one-step detection of specific antigens.
(20) The CdTe QDs were synthesized at 60° C. during 6 h, by using 15 mM of citrate buffer, at pH 9.0, 1 mM K.sub.2TeO.sub.3, 4 mM CdCl.sub.2 and 10 mM GSH, according to the previously described instructions.
(21) The CdTe-GSH QDs were joined to the protein with the help of 2 imino thiolane. The protein was an antibody (Ab) recognizing the food-contaminating agent Salmonella enterica serovar Typhimurium. This complex Ab+NPs was used for detecting the pathogenic agent.